Page 268 - PROGRAMME2018

P-428 Lipidomic analysis reveals increased TXA2 presence in non-receptive endometrium of recurrent miscarriage and repeated implantation failure patients
E. Bastu1, I. Demiral2, E. Ulgen3, M.B. Erkan4, S.E. Celik5, Y. Aydin4, A.N. Onem5, B. Yuksel Ozgor2, M. Dogan2, R. Apak5, U. Sezerman3, F. Buyru2
1Acibadem University Faculty of Medicine, Department of Obstetrics and Gynecology, Istanbul, Turkey 2Istanbul University School of Medicine, Department of Obstetrics and Gynecology, Istanbul, Turkey 3Acibadem University, Department of Biostatistics and Medical Informatics, Istanbul, Turkey 4Istanbul University Faculty of Science, Department of Biology, Istanbul, Turkey
5Istanbul University Faculty of Engineering, Department of Chemistry, Istanbul, Turkey
P-429 Ectopic pregnancy and endometrial thickness in assisted reproduction cycles: is there a link?
S. Mattar1,2, L. Lapensée1,2, C. Sylvestre1,2, A. Eberle3, S. Phillips1,2, R. Antaki1,2
1Université de Montréal, Obstetrics & Gynecology- division of Reproductive Endocrinology & Infertility, Montreal, Canada
2Ovo Clinic, Ovo Fertility, Montreal, Canada
3Université de Montréal, Faculty of Medicine, Montreal, Canada
P-430 Danaparoid is effective and safe for patients with obstetric antiphospholipid syndrome
H. Yoshihara1, M. Sugiura-Ogasawara1, C. Bannno1, T. Kitaori1, Y. Ozaki1, K. Katano1, N. Suzumori1 1Nagoya City University -Gradeate School of Medical Science, Obstetrics and Gynecology, Nagoya, Japan
P-431 Serum 17-alpha-hydroxyprogesterone (Sr. 17-α-OHP): a precocious early indicator of implantation and gestational status in double embryo-transfer fresh IVF cycles
B.N. Chimote1, N. Chimote2
1Vaunshdhara Clinic & Assisted Conception Centre, Embryology- Endocrinology, Nagpur, India 2Vaunshdhara Clinic and Assisted Conception Centre, Endocrinology- Embryology, Nagpur, India
P-432 Endometrial transcriptomic pathways analysis in recurrent miscarriages and unexplained infertility
I. Demiral1, E. Gumusoglu2, E. Ulgen3, M. Hosseini2, B. Yuksel Ozgor1, M. Dogan4, A. Nehir Aytan1, U. Sezerman3, T. Gunel2, E. Bastu4
1Istanbul University School of Medicine, Obstetrics and Gynecology, Istanbul, Turkey
2Istanbul University, Molecular Biology and Genetics, Istanbul, Turkey
3Acibadem University School of Medicine, Biostatistics and Medical Informatics, Istanbul, Turkey 4Acibadem University School of Medicine, Obstetrics and Gynecology, Istanbul, Turkey
P-433 Prostaglandin E2 receptor 3 (EP3) signaling is induced in placentas of patients with unexplained recurrent pregnancy losses (uRPL)
Y. Ye1, A. Vattai1, N. Ditsch1, C. Kuhn1, M. Rahmeh1, S. Mahner1, M. Ripphahn2, R. Immler2, M. Sperandio2, U. Jeschke1, V. Von Schönfeldt1
1Ludwig-Maximilians-University of Munich- Germany, Department of Obstetrics and Gynecology, Munich, Germany
2Ludwig-Maximilians-University of Munich- Germany, Department of Cardiovascular Physiology and Pathophysiology, Munich, Germany
268